Loading...
VLS logo

Vita Life Sciences Community

ASX:VLS Community
  • 1 Narratives written by author
  • 2 Comments on narratives written by author
  • 45 Fair Values set on narratives written by author

Community Investing Ideas

VLS logo
Vita Life Sciences

Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges

Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed Momentum Vita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and supplements across the Asia-Pacific region. Founded in 1947, the company boasts strong brand recognition through its labels such as VitaHealth, Herbs of Gold, VitaScience, and VitaLife, offering over 350 premium healthcare and pharmaceutical products.

View narrative
1users have liked this narrative
2users have commented on this narrative
30users have followed this narrative
AU$2.42
0.8% undervalued intrinsic discount
Robbo Fair Value
Revenue growth
12.72% p.a.
Profit Margin
11.05%
Future PE
11.43x
Share price in 2030
AU$3.22